Publicacións (119) Publicacións de MI KWON KIM

filter_list

2025

  1. Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT

    Bone Marrow Transplantation

  2. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study

    HemaSphere

  3. Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy

    British Journal of Haematology, Vol. 206, Núm. 1, pp. 195-203

  4. Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT

    Bone Marrow Transplantation, Vol. 60, Núm. 4, pp. 529-534

  5. Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT

    Bone Marrow Transplantation

  6. Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study: IMMUNOTHERAPY

    Leukemia, Vol. 39, Núm. 2, pp. 431-437

  7. Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

    JAMA network open, Vol. 8, Núm. 2, pp. e2461683

  8. Real-world use of isavuconazole in adult oncohematology patients

    Revista Iberoamericana de Micologia

  9. Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT

    Bone Marrow Transplantation

  10. Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults

    Experimental Hematology and Oncology, Vol. 14, Núm. 1

  11. Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy: LYMPHOMA

    Leukemia, Vol. 39, Núm. 5, pp. 1196-1205

  12. Successful allogeneic CD34+ hematopoietic stem cell boost for prolonged cytopenias following CAR T-cell therapy in B-cell acute lymphoblastic leukemia. On behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

    Bone Marrow Transplantation

  13. The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide

    Bone Marrow Transplantation, Vol. 60, Núm. 4, pp. 499-506

2024

  1. Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy

    Blood transfusion = Trasfusione del sangue, Vol. 22, Núm. 3, pp. 239-245

  2. Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO

    Transplantation and Cellular Therapy, Vol. 30, Núm. 10, pp. 988.e1-988.e11

  3. Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.

    New England Journal of Medicine, Vol. 391, Núm. 11, pp. 1002-1014

  4. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC

    Transplantation, Vol. 108, Núm. 10, pp. 2134-2143

  5. Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment

    Journal of Hematology and Oncology, Vol. 17, Núm. 1

  6. Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients

    Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12

  7. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study

    The Lancet HIV, Vol. 11, Núm. 6, pp. e389-e405